Pharmaceuticals and life sciences (Pharma) CEOs are faced with the challenges of a continually changing world in the New Health Economy, with ever closer scrutiny of pricing and value delivery from empowered patients and cash-conscious payers. Despite this, they’re positive about their ability to grow their companies over the short and medium terms. They’re planning a range of activities to achieve this but remain concerned about factors such as regulation and the ability to recruit the skills they need.